Press Releases


SunTrust Robinson Humphrey Therapeutics Conference to Webcast Alkermes' Corporate Presentation

CAMBRIDGE, Mass., May 10, 2004 (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by SunTrust Robinson Humphrey on Tuesday, May 11, 2004 at 11:05am EDT. The presentation will be webcast from Le Parker Meridien Hotel in New York and may be accessed under the investor relation's tab at www.alkermes.com. The presentation will be archived for 14 days.

Alkermes, Inc. is an emerging pharmaceutical company developing products based on its sophisticated drug delivery technologies to enhance therapeutic outcomes. Our areas of focus include: controlled, extended-release of injectable drugs utilizing our ProLease(R) and Medisorb(R) delivery systems and the development of inhaled pharmaceutical products based on our proprietary AIR(R) pulmonary delivery system. Our business strategy is twofold. We partner our proprietary technology systems and drug delivery expertise with many of the world's finest pharmaceutical companies and also develop novel, proprietary drug candidates for our own account. In addition to our Massachusetts headquarters, research and manufacturing facilities, we operate research and manufacturing facilities in Ohio.

SOURCE: Alkermes, Inc.

Rebecca Peterson
Director, Corporate Communications
Alkermes, Inc.
(617) 583-6378
Customize your Business Wire news & multimedia to match your needs.
Get breaking news from companies and organizations worldwide.
Logon for FREE today at www.BusinessWire.com.